MedPath

赛诺菲（北京）制药有限公司

Ownership
-
Established
1995-12-25
Employees
-
Market Cap
-
Website
www.medtrio.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Glimepiride Tablets

Product Name
亚莫利
Approval Number
国药准字H20057672
Approval Date
Sep 25, 2024
NMPA

Insulin Glargine Solution for Injection

Product Name
甘精胰岛素注射液
Approval Number
国药准字S20237010
Approval Date
Oct 10, 2023
NMPA

Ramipril Tablets

Product Name
瑞泰
Approval Number
国药准字H20060766
Approval Date
Dec 4, 2020
NMPA

Insulin Glargine Injection

Product Name
甘精胰岛素注射液
Approval Number
国药准字S20201000
Approval Date
Feb 5, 2020
NMPA

Insulin Glargine Injection

Product Name
甘精胰岛素注射液
Approval Number
国药准字S20201001
Approval Date
Feb 5, 2020
NMPA

Polyene Phosphatidylcholine Capsules

Product Name
易善复
Approval Number
国药准字H20059010
Approval Date
Jan 23, 2020
NMPA

Glimepiride Tablets

Product Name
格列美脲片
Approval Number
国药准字H20057673
Approval Date
Apr 1, 2015
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy